Publication Catalogue

Publications of the Department of Bacterial and Inflammatory Diseases 2008

A. Original articles and reviews

  1. Bakari M, Arbeit RD, Mtei L, Lyimo J, Waddell R, Matee M, Cole BF, Tvaroha S, Horsburgh CR, Soini H, Pallangyo K, von Reyn CF: Basis for treatment of tuberculosis among HIV-infected patients in Tanzania: the role of chest x-ray and sputum culture. BMC Infectious Diseases 2008;8:32.
  2. Beldi G, Wu Y, Banz Y, Nowak M, Miller L, Enjyoji K, Haschemi A, Yegutkin GG, Candinas D, Exley M, Robson SC: Natural Killer T Cell Dysfunction in CD39-Null Mice Protects Against Concanavalin A-Induced Hepatitis. HEPATOLOGY 2008;48:841-852.
  3. Bergman M, Nyberg ST, Huovinen P, Paakkari P, Hakanen AJ, the Finnish Study Group for Antimicrobial Resistance (FiRe N: Association between Antimicrobial Consumption and Resistance in Escherichia coli. Antimicrob Agents Chemother 2008(Dec 22).
  4. Biedzka-Sarek M, Salmenlinna S, Gruber M, Lupas A, Meri S, Skurnik M: Functional mapping of YadA- and Ail –mediated binding of human factor H to Yersinia enterocolitica serotype O:3. Infect Immun 2008;76:5016-5027.
  5. Bonnedahl J, Olsen B, Waldenström J, Broman T, Jalava J, Huovinen P, Österblad M: Antibiotic susceptibility of faecal bacteria in Antarctic penguins. Polar Biology 2008;31:759-763.
  6. Brazier, J, Chmelar, D, Dudreuil, L, Feierl, G, Hedberg, M, Kalenic, S, Könönen, E, Lundgren, B, Malamou-Ladas, H, Nagy, E, Sullivan, A, Nord, CE: European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci. International Journal of Antimicrobial Agents 2008;31:316-320.
  7. Frandsen EV, Poulsen K, Könönen E, Kilian M: Diversity of capnocytophaga species in children and description of capnocytophaga leadbetteri sp. International journal of systematic and evolutionary microbiology 2008;58:324-36.
  8. Gursoy UK, Könönen E, Uitto VJ: Intracellular replication of fusobacteria requires new actin filament formation of epithelial cells. APMIS 2008;116:1063-1070.
  9. Gursoy UK, Könönen E, Uitto VJ: Stimulation of epithelial cell matrix metalloproteinase (MMP-2,-9,-13) and interleukin-8 secretion by fusobacteria. Oral Microbiol Immunol 2008;23:432-434.
  10. Gürsoy, M, Pajukanta, R, Sorsa, T, Könönen, E: Clinical changes in periodontium during pregnancy and post-partum. J Clin Periodontol 2008;35:576-583.
  11. Haanperä M, Forssten SD, Huovinen P, Jalava J: Typing of SHV extended-spectrum beta-lactamases by pyrosequencing in Klebsiella pneumoniae strains with chromosomal SHV beta-lactamase. Antimicrob Agents Chemother 2008;52:2632-2635.
  12. Haapasalo K, Jarva H, Siljander T, Tewodros W, Vuopio-Varkila J, Jokiranta T: Complement factor H allotype 402H is associated with increased C3b opsonization and phagocytosis of Streptococcus pyogenes. Mol Microbiol 2008;70:583-594.
  13. Haukka K, Siitonen A: Emerging resistance to newer antimicrobial agents among Shigella isolated from Finnish foreign travellers. Epidemiol Infect 2008;136:476-82.
  14. He Q, Mertsola J: Factors contributing to pertussis resurgence. Future Microbiology 2008;3:329-339.
  15. Heikkinen E, Xing DK, Ölander R, Hytönen J, Viljanen MK, Mertsola J, He Q: Bordetella pertussis isolates in Finland: Serotype and fimbrial expression. BMC Microbiology 2008;8.
  16. Hijnen M, He Q, Schepp R, Van Gageldonk P, Mertsola J, Mooi FR, Berbers GAM: Antibody responses to defined regions of the Bordetella pertussis virulence factor pertactin. Scand J Infect Dis 2008;40:94-104.
  17. Ibrahem S, Salmenlinna S, Lyytikäinen O, Vaara M, Vuopio-Varkila J: Molecular characterization of methicillin-resistant Staphylococcus epidermidis strains from bacteraemic patients. Clinical microbiology and infection 2008;14:1020-1027.
  18. Ibrahem S, Salmenlinna S, Virolainen A, Kerttula A, Lyytikäinen O, Jägerroos H, Broas M, Vuopio-Varkila J: Carriage of methicillin- resistant staphylococci and their SCCmec types in a long term care facility. J Clin Microbiol 2008(Oct 29).
  19. Jalkanen S, Salmi M: VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation. Arterioscler Thromb Vasc Biol 2008;28:18-26.
  20. Jalkanen, S, Salmi, M: VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation. Arteriosclerosis, Thrombosis, and Vascular Biology 2008;28:18-26.
  21. Kangas S, Takkinen J, Hakkinen M, Nakari U, Johansson T, Henttonen H, Virtaluoto L, Siitonen A, Ollgren J, Kuusi M: Yersinia pseudotuberculosis O:1 traced to raw carrots, Finland. Emerging Infectious Diseases 2008;14:1959-1961.
  22. Kantele AM, Palkola NV, Arvilommi HS, Kantele JM: Distinctive homing profile of pathogen-specific activated lymphocytes in human urinary tract infection. Clinical Immunology 2008;128:427-434.
  23. Kantele A, Palkola N, Arvilommi H, Honkinen O, Jahnukainen T, Mertsola J, Kantele JM: Local immune response to upper urinary tract infections in children. Clinical and Vaccine Immunology 2008(Jan 9).
  24. Kerttula AM, Mero S, Pasanen T, Vuopio-Varkila J, Virolainen A: Evaluation of phenotypic and molecular methods for screening and detection of methicillin-resistant Staphylococcus aureus. Scand J Infect Dis 2008;40:663-666.
  25. Khalangot M, Tronko M, Kravchenko V, Kulchinska J, Hu G: The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes. DIABETES RES CLIN PRACT 2008;82:139-147.
  26. Kilkkinen A, Rissanen H, Klaukka T, Pukkala E, Heliövaara M, Huovinen P, Männistö S, Aromaa A: Antibiotic use predicts and increased risk of cancer . Int J Cancer 2008;123:2152-2155.
  27. King AJ, van Gorkom T, Pennings JLA, van der Heide HGJ, He Q, Diavatopoulus D, Heuvelman K, van Gent M, van Leeuwen K, Mooi FR: Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: Identification of genes absent from epidemic strains. BMC Genomics 2008;9.
  28. Kiss J, Jalkanen S, Fülöp F, Savunen T, Salmi M: Ischemia-reperfusion injury is attenuated in VAP-1-deficient mice and by VAP-1 inhibitors. Eur J Immunol 2008;38:3041-3049.
  29. Koort JK, Mäkinen TJ, Suokas E, Veiranto M, Jalava J, Törmälä P, Aro HT: Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant. Acta Orthopaedica 2008;79:295-301.
  30. Kuijper EJ, Barbut F, Brazier J, Kleinkauf N, Eckmanns T, Lambert M, Drudy D, Fitzpatrick F, Wiuff C, Brown D, Coia J, Pituch H, Reichert P, Even J, Mossong J, Widmer A, Olsen K, Allerberger F, Notermans D, Delmée M, Coignard B, Wilcox M, Patel B, Frei R, Nagy E, Bouza E, Marin M, Akerlund T, Virolainen-Julkunen A, Lyytikäinen O, Kotila S, Ingebretsen A, Smyth B, Rooney P, Poxton I, Monnet D: Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. EuroSurveillance 2008;12:18942.
  31. Kuipers JG, Sibilia J, Bas S, Gaston H, Granfors K, Vischer TL, Hajjaj-Hassouni N, Ladjouze-Rezig A, Sellami S, Wollenhaupt J, Zeidler H, Schumacher HR, Dougados M: Reactive and undifferentiated arthritis in North Africa: use of PCR for detection of Chlamydia trachomatis. CLIN RHEUMATOL 2008(Aug 8).
  32. Kärpänoja P, Nyberg ST, Bergman M, Voipio T, Paakkari P, Huovinen P, Sarkkinen H, the Finnish Study Group for Antimicrobial Resistance (FiRe N: Connection between Trimethoprim-Sulfamethoxazole Use and Resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Antimicrob Agents Chemother 2008;52:2480-2485.
  33. Lamagni T, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B, Vuopio-Varkila J, Bouvet A, Creti R, Edelund K, Koliou M, Reinert RR, Stathi A, Strakova L, Ungureanu V, Schalén C: The epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 2008;46:2359-2367.
  34. Lamagni TL, Neal S, Keshishian C, Hope V, George R, Duckworth G, Vuopio-Varkila J, Efstratiou A: Epidemic of severe Streptococcus pyogenes infections in injecting drug users in the UK, 2003-2004. CLIN MICROBIOL REV 2008;14:1002-1009.
  35. Lamagni T, Neal S, Keshishian C, Alhaddad N, George R, Duckworth G, Vuopio-Varkila J, Efstratiou A: Severe Streptococcus pyogenes infections in the UK, Channel Islands and the Isle of Man 2003-04. Emerging Infectious Diseases 2008;14:201-209.
  36. Lankinen P, Mäkinen TJ, Pöyhönen TA, Virsu P, Salomäki S, Hakanen AJ, Jalkanen S, Aro HT, Roivainen A: 68Ga-DOTAVAP-P1 PET imaging capable of demonstrating the phase of inflammation in healing bones and the progress of infection in osteomyelitic bones. European Journal of Nuclear Medicine and Molecular Imaging 2008;35:352-364.
  37. Lindgren M, Löfmark S, Edlund C, Huovinen P, Jalava J: Prolonged impact of a one-week course of clindamycin on Enterococcus spp. in human normal microbiota. Scand J Infect Dis 2008(dec 23):1-5.
  38. Lindhe J, Meyle J, Group D of European Workshop on Periodontology: Peri-implant diseases: Consensus Report of the Sixth European Workshop on Periodontology. J Clin Periodontol 2008;35:282-285.
  39. Martelius T, Salmi M, Krogerus L, Loginov R, Schoultz M, Karikoski M, Miiluniemi M, Soots A, Höckerstedt K, Jalkanen S, Lautenschlager I: INHIBITION OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASES DECREASES LYMPHOCYTE INFILTRATION IN THE EARLY PHASES OF RAT LIVER ALLOGRAFT REJECTION. International Journal of Immunopathology and Pharmacology 2008;21:911-920.
  40. Marttila HJ, Mäkinen J, Marjamäki M, Ruutu P, Soini H: Molecular genetics of drug-resistant Mycobacterium tuberculosis isolates in Finland, 1995-2004. International Journal of Tuberculosis and Lung Disease 2008;12:338-343.
  41. Marttila HJ, Mäkinen J, Marjamäki M, Soini H: Prospective evaluation of pyrosequencing for the rapid detection of isoniazid and rifampin resistance in clinical Mycobacterium tuberculosis isolates. Eur J Clin Microbiol Infect Dis 2008(Aug 22).
  42. Marttila-Ichihara F, Turja R, Miiluniemi M, Karikoski M, Maksimow M, Niemelä J, Martinez-Pomares L, Salmi M, Jalkanen S: Macrophage mannose receptor on lymphatics controls cell trafficking. Blood 2008;112:64-72.
  43. Matee M, Mtei L, Lounasvaara T, Wieland-Alter W, Waddell R, Lyimo J, Bakari M, Pallangyo K, Von Reyn CF: Sputum microscopy for the diagnosis of HIV-associated pulmonary tuberculosis in Tanzania. BMC Public Health 2008;8:68.
  44. Melin M, Jarva H, Siira L, Meri S, Käyhty H, Väkeväinen M: Streptococcus pneumoniae capsular serotype 19F is more resistant to C3 deposition and less sensitive to opsonophagocytosis than serotype 6B. Infect Immun 2008.
  45. Mentula S, Tuure T, Koskenala R, Korpela R, Könönen E: Faecal fermentation capacity and microbiota of colicky infants – a probiotic supplementation pilot. Microbial ecology in health and disease 2008;20:37-47.
  46. Mikoluc B, Käyhty H, Bernatowska E, Motkowski R: Immune response to the 7-valent pneumococcal conjugate vaccine in 30 asplenic children. Eur J Clin Microbiol Infect Dis 2008;27:923-928.
  47. Nakari, UM, Puhakka, A, Siitonen, A: Correct identification and discrimination between Campylobacter jejuni and C. coli by a standardized hippurate test and species-specific polymerase chain reaction. Eur J Clin Microbiol Infect Dis 2008;27:513-518.
  48. Niemelä J, Ifergan I, Yegutkin GG, Jalkanen S, Prat A, Airas L: IFN-Beta regulates CD73 and adenosine expression at the blood-brain barrier. Eur J Immunol 2008;38:2718-2726.
  49. Nissinen A, Strandén P, Myllys R, Takkinen J, Björkman Y, Leinikki P, Siitonen A: Point-of-care testing group A streptococcal antigen: performance evaluated by external quality assessment. Eur J Clin Microbiol Infect Dis 2008.
  50. Nyberg SD, Meurman O, Jalava J, Rantakokko-Jalava K: Evaluation of detection of extended-spectrum beta-lactamases among Escherichia coli and Klebsiella spp. isolates by VITEK 2 AST-N029 compared to the agar dilution and disk diffusion methods. Scand J Infect Dis 2008;40:355-362.
  51. Paju S, Pussinen P, Suominen-Taipale L, Hyvönen M, Knuuttila M, Könönen E: Detection of multiple pathogenic species in saliva associates with periodontal infection in adults. J Clin Microbiol 2008.
  52. Pitkänen T, Miettinen IT, Nakari U, Takkinen J, Nieminen K, Siitonen A, Kuusi M, Holopainen A, Hänninen M: Faecal contamination of a municipal drinking water distribution system in association with Campylobacter jejuni infections. Journal of Water and Health 2008(6.3.2008):365-376.
  53. Rimhanen-Finne R, Niskanen T, Hallanvuo S, Makary P, Haukka K, Pajunen S, Siitonen A, Ristolainen R, Pöyry H, Ollgren J, Kuusi M: Yersinia pseudotuberculosis causing a large outbreak associated with carrots in Finland, 2006. Epidemiol Infect 2008.
  54. Rosenmeier JB, Yegutkin GG, González-Alonso J: Activation of ATP/UTP-selective receptors increases blood flow and blunts sympathetic vasoconstriction in human skeletal muscle. J PHYSIOL (LOND) 2008;586:4993-5002.
  55. Ruotsalainen E, Karden-Lilja M, Kuusela P, Vuopio-Varkila J, Virolainen-Julkunen A, Sarna S, Valtonen V, Järvinen A: Methicillin-sensitive Staphylococcus aureus bacteraemia and endocarditis among injection drug users and nonaddicts: Host factors, microbiological and serological characteristics. J Infect Dis 2008;56:249-256.
  56. Ruotsalainen E, Vauhkonen I, Salmenniemi U, Pihlajamäki J, Punnonen K, Kainulainen S, Jalkanen S, Salmi M, Laakso M: Markers of endothelial dysfunction and low-grade inflammation are associated in the offspring of type 2 diabetic subjects. Atherosclerosis 2008;197:271-277.
  57. Ruotsalainen, E, Karden-Lilja, M, Kuusela, P, Vuopio-Varkila, J, Virolainen-Julkunen, A, Sarna, S, Valtonen, V, Järvinen, A: Methicillin-sensitive staphylococcus aureus bacteraemia and endocarditis among injection drug users and nonaddicts: Host factors, microbiological and serological characteristics. J Infect 2008(EpubFeb29).
  58. van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, Ferech M, the European Antimicrobial Resistance Surveillance System an: Antimicrobial Drug Use and Resistance in Europe. Emerging Infectious Diseases 2008;14:1722-1730.
  59. Siljander T, Lyytikäinen O, Vähäkuopus S, Säilä P, Jalava J, Vuopio-Varkila J: Rapid emergence of type emm84 among invasive Streptococcus pyogenes infections in Finland. J Clin Microbiol 2008(dec 10).
  60. Siljander, T, Karppelin, M, Vähäkuopus, S, Syrjänen, J, Toropainen, M, Kere, J, Vuento, R, Jussila, T, Vuopio-Varkila, J: Acute bacterial, nonnecrotizing cellulitis in Finland: microbiological findings. Clin Infect Dis 2008;46:855-61.
  61. Skov R, Gudlaugsson O, Hardardottir H, Harthug S, Jakobsen T, Kolmos HJ, Olsson-Liljequist B, Peltonen R, Tveten Y, Vuopio-Varkila J, Ahren C: Proposal for common Nordic epidemiological terms and definitions for methicillin-resistant Staphylococcus aureus (MRSA). Scand J Infect Dis 2008;40:495-502.
  62. Sombrero L, Nissinen A, Esparar G, Lindgren M, Siira L, Virolainen A, ARIVAC : Low incidence of antibiotic resistance among invasive and nasopharyngeal isolates of Streptococcus pneumoniae from children in rural Philippines between 1994 and 2000. Eur J Clin Microbiol Infect Dis 2008;27:929-935.
  63. Suvilehto, J, Jarva, H, Seppänen, M, Siljander, T, Vuopio-Varkila, J, Meri, S: Binding of complement regutors factor H and C4b binding protein to group A streptococcal strains isolated from tonsillar tissue and blood. Microbes and Infection 2008;10:757-763.
  64. Tahvanainen J, Kallonen T, Lähteenmäki H, Heiskanen KM, Westermarck J, Rao KVS, Lahesmaa R: PRELI is a mitochondrial regulator of human primary T helper cell apoptosis, STAT6 and Th2 cell differentiation. Blood 2008(Oct 22).
  65. Vainio A, Karden-Lilja M, Ibrahem S, Kerttula AM, Salmenlinna S, Virolainen A, Vuopio-Varkila J: Clonality of epidemic methicillin-resistant Staphylococcus aureus strains in Finland as defined by several molecular methods. Eur J Clin Microbiol Infect Dis 2008;27:545-555.
  66. Varhimo E, Savijoki K, Jefremoff H, Jalava J, Sukura A, Varmanen P: Ciprofloxacin induces mutagenesis to antibiotic resistance independt of UmuC in Streptococcus uberis. Environmental Microbiology 2008;10:2179-2183.
  67. Werner G, Coque T, Hammerum A, Hope R, Hryniewicz W, Johnson A, Klare I, Kristinsson K, Leclercq R, Lester C, Lillie M, Novais C, Olsson-Liljequist B, Peixe L, Sadowy E, Simonsen G, Top J, Vuopio-Varkila J, Willems R, Witte W, Woodford N: Emergence and spread of vancomycin resistance among enterococci in Europe. EuroSurveillance 2008;13.
  68. Yegutkin GG: Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochim Biophys Acta 2008;1783:673-694.
  69. Yegutkin GG, Jankowski J, Jalkanen S, Günthner T, Zidek W, Jankowski V: Dinucleotide polyphosphates contribute to purinergic signalling via inhibition of adenylate kinase activity. BIOSCI REP 2008;28:189-194.
  70. Zhao L, Fong Y, Granfors K, Gu J, Yu D: Identification of cytokines that might enhance the promoter activity of HLA-B27. J Rheumatol 2008;35:862-868.

B. Original articles and reviews published in domestic languages

  1. Hakanen A, Bergman M, Huovinen P, Fire-ryhmä: Bakteerien lääkeherkkyystilanne Suomessa vuonna 2007. Kansanterveys - the Bulletin of National Public Health Institute of Finland 2008(9):22-23.
  2. Haukka K, Kuusi M, Siitonen A: Burkina Fasossa puhdas vesi on ylellisyyttä. Kansanterveys - the Bulletin of National Public Health Institute of Finland 2008(2):16.
  3. Haukka K, Kuusi M, Siitonen A: Taudinaiheuttajat ovat todellisia maailmanmatkaajia. Kansanterveys - the Bulletin of National Public Health Institute of Finland 2008(2):16.
  4. Huovinen P: Läskissä muhii tulehdus - bakteerit asialla? Duodecim 2008;124:123-124.
  5. Jalkanen S: Adheesiomolekyyleistäkö apua? Duodecim 2008;124:1746-1752.
  6. Pitkänen T, Hokajärvi A, Miettinen I, Siitonen A, Roivainen M: Suolistoinfektioita aiheuttavat mikrobit jätevedessä. Kansanterveys - the Bulletin of National Public Health Institute of Finland 2008(2):4-5.
  7. Riihelä K, Siitonen A: Heikentyvätkö tarttuvien tautien laboratoriopalvelut? Suom Lääkäril 2008;63:72-73.
  8. Salmenlinna S: Avohoidon MRSA Suomessa ja maailmalla. Suomen sairaalahygienialehti 2008;26:135-140.
  9. Salmenlinna S, Lyytikäinen O, Kanerva M, Vuopio-Varkila J: MRSA:n epidemiologia Suomessa. Moodi 2008;5:190-193.
  10. Siitonen A, Kuronen H, Pelkonen S: Kotimainen salmonellatilanne - katsaus. Suomen eläinlääkärilehti 2008(3):139-144.
  11. Siitonen A, Lyytikäinen O: Salmonellat ja muut ”ruokamyrkytysbakteerit” hoitoon liittyvien infektioiden aiheuttajina Suomessa. Suomen sairaalahygienialehti 2008;26:70-74.
  12. Vuopio-Varkila J: Avohoidon MRSA: Virulenssitekijät. Suomen sairaalahygienialehti 2008;26:141-144.

C. Textbooks and chapters in textbooks, reports and proceedings

  1. Huovinen P, Matilanen I: Taibupõnn bakterite maailmas. Helsinki: Välja antud kirjastuse WSOY lepingu alusel, 2008. 65 p.
  2. Jalava K, Lukinmaa S, Siitonen A, Kuusi M: Enterohemorraginen Escherichia coli EHEC. In: Hulkko T, Lyytikäinen O, Kuusi M, Iivonen J, Ruutu P ed. Tartuntataudit Suomessa 2007. 2008:16. (Kansanterveyslaitoksen julkaisuja B10/2008/2008).
  3. Jalkanen S, Salmi M: Lymphocyte adhesion and traffing. In: Rich RR, Fleisher TA, Shearer WT, Schroeder HW, Frew AJ, Weyand CM ed. Clinical Immunology: Principles and Practice. Elsevier Limited, 2008:197-209.
  4. Kuusi M, Ruotsalainen E, Laine J, Rimhanen-Finne R, Siitonen A: Elintarvike- ja vesivälitteiset epidemiat. In: Hulkko T, Lyytikäinen O, Kuusi M, Iivonen J, Ruutu P ed. Tartuntataudit Suomessa 2007. 2008:18-20. (Kansanterveyslaitoksen julkaisuja B10/2008/2008).
  5. Kuusi M, Siitonen A: Shigellat. In: Hulkko T, Lyytikäinen O, Kuusi M, Iivonen J, Ruutu P ed. Tartuntataudit Suomessa 2007. 2008:15-16. (Kansanterveyslaitoksen julkaisuja B10/2008/2008).
  6. Siitonen A, Rimhanen-Finne R: Salmonella. In: Hulkko T, Lyytikäinen O, Kuusi M, Iivonen J, Ruutu P ed. Tartuntataudit Suomessa 2007. 2008:11-13. (Kansanterveyslaitoksen julkaisuja B10/2008/2008).
  7. Vuopio-Varkila J, Kotilainen P: Metisilliiniresistentti Staphylococcus aureus (MRSA). In: Kunnamo I, Alenius H, et al. ed. Lääkärin käsikirja. Kustannus Oy Duodecim, 2008:14-16.

D. Other publications

  1. Huovinen P: Hiljainen kriisi. Kansanterveys - the Bulletin of National Public Health Institute of Finland 2008(2):2.
  2. Huovinen P: Ilmastonmuutos on terveysuhka. Kansanterveys - the Bulletin of National Public Health Institute of Finland 2008(3):2.
  3. Huovinen P: Mikrobit odottavat virheitämme. Kansanterveys - the Bulletin of National Public Health Institute of Finland 2008(1):2.
  4. Huovinen P: Nuori tarvitsee vanhempiaan. Kansanterveys - the Bulletin of National Public Health Institute of Finland 2008(4):2.
  5. Huovinen P: Nyt tehdään päätöksiä lasten ja nuorten terveydestä. Kansanterveys - the Bulletin of National Public Health Institute of Finland 2008(7):2.
  6. Huovinen P: Onneksi on tutkittua tietoa. Kansanterveys - the Bulletin of National Public Health Institute of Finland 2008(5-6):2.
  7. Huovinen P, Kuronen M: Sydämelliset kiitokset ja haikeat jäähyväiset. Kansanterveys - the Bulletin of National Public Health Institute of Finland 2008(9):2.
  8. Riley TV, Huovinen P: Infection control measures to limit the spread of Clostridium difficile - Introduction [editorial]. Clinical microbiology and infection 2008;14(Suppl. 5):1.

E. Theses

  1. Elomaa A: Bordetella pertussis Vaccination and Strain Variation [dissertation]. Turku: Turun Yliopisto, 2008. 118 p. (Medica - Odontologica sarj D osa 831/2008).
  2. Haveri M: Staphylococcus aureus in bovine intramammary infection: Molecular, clinical and epidemiological characteristics [dissertation]. Helsinki: Helsinki University Print, 2008. 79 p.
  3. Kiss J: THE ROLE OF ENDOTHELIAL ENZYMES NOS, VAP-1 AND CD73 IN ACUTE LUNG INJURY [dissertation]. Turku: Turun Yliopisto, 2008. 99 p. (Medica - Odontologica sarja D osa 81/2008).
  4. Lamagni T: The epidemiology of severe Streptococcus pyogenes disease in Europe [dissertation]. Helsinki: National Public Health Institute, 2008. 102 p. (Publications of the National Public Health Institute A 28/2008/2008).